Longeveron® Announces Positive Type C Meeting With U.S. FDA Regarding Pathway to Bla for Lomecel-B™ in Hypoplastic Left Heart Syndrome (Hlhs)
Longeveron®宣佈與美國FDA進行了關於Lomecel-B™在低血容量性左心綜合徵(HLHS)中Bla路徑的積極C型會議。
Longeveron® Announces Positive Type C Meeting With U.S. FDA Regarding Pathway to Bla for Lomecel-B™ in Hypoplastic Left Heart Syndrome (Hlhs)
Longeveron®宣佈與美國FDA進行了關於Lomecel-B™在低血容量性左心綜合徵(HLHS)中Bla路徑的積極C型會議。
譯文內容由第三人軟體翻譯。